Cargando…
Assessing Muscle-Related Adverse Events in Randomized Trials of Statins
Autores principales: | Doshi, Peter, Hong, Kyungwan, Tanveer, Sarah, Jefferson, Tom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926089/ https://www.ncbi.nlm.nih.gov/pubmed/35296985 http://dx.doi.org/10.1007/s11606-022-07485-6 |
Ejemplares similares
-
Evaluation of Publicly Available Information on Sex-Related Differences in the Efficacy and Safety of Newly Approved Medications
por: Hong, Kyungwan, et al.
Publicado: (2022) -
Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD)
por: Mielnik, Pawel, et al.
Publicado: (2023) -
Adverse events of raltegravir and dolutegravir
por: Elzi, Luigia, et al.
Publicado: (2017) -
Adjuvant-containing control arms in pivotal quadrivalent human papillomavirus vaccine trials: restoration of previously unpublished methodology
por: Doshi, Peter, et al.
Publicado: (2020) -
Protocol for analyses of adverse event data from randomized controlled trials of statin therapy
Publicado: (2016)